Harm Reduction Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
Since launching in 2004 under the editorship of Prof Ernest Drucker, Harm Reduction Journal has been at the forefront of publishing high quality peer-reviewed research on the harm reduction approach to drugs and addiction.
Now, after 15 successful years, explore highlights by Harm Reduction Journal over the years, including our specially curated anniversary collection.
Aims and scope
Harm Reduction Journal publishes research focusing on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define 'harm reduction' as 'policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption'.
Call for papers: Reducing harm among illicit stimulant users
Although alcohol and tobacco remain the most prevalent substances used worldwide, use of amphetamine-type substances (ATS) and cocaine is substantial.
Harm Reduction Journal hereby invites you to submit manuscripts for our special issue of the journal on State of the art and best-practice interventions for reducing harm among illicit stimulant users.
Visit our Substance Use page
Harm Reduction International is a leading NGO dedicated to reducing the negative health, social and legal impacts of drug use and drug policy. We promote the rights of people who use drugs and their communities through research and advocacy to help achieve a world where drug policies and laws contribute to healthier, safer societies. The organisation is an NGO in Special Consultative Status with the Economic and Social Council of the United Nations.
Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. Our efforts advance harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing that social inequality and injustice magnify drug-related harm and limit the voice of our most vulnerable communities, we work to uphold every individual’s right to health and well-being and their competence to participate in the public policy dialogue.
Annual Journal Metrics
58 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
94 days from submission to acceptance
21 days from acceptance to publication
2253 Altmetric mentions